2022 | Q4 Newsletter
Welcome to the 2022 Q4 Newsletter. Life Sciences Pennsylvania has been working tirelessly to advocate on your behalf and provide opportunities for you to connect within the life sciences industry. We hope this recap of the past quarter provides you with the optimism we hold each day for the Association and the industry.
CLICK BELOW TO EXPLORE
John Witkowski, President of DSM Biomedical joins hosts Chris and Rachael in the studio to record Being a Life Sciences Leader.
BEING A LIFE SCEINCES LEADER
Season 2 of Being a Life Sciences Leader launched in Q4 with a live recording of the podcast during LSPA’s signature Life Sciences Future - BioPharm conference. Hosts Chris Molineaux and Rachael Bushey interviewed Ron Philip, CEO of Spark Therapeutics in front of a live studio audience where they learned how his childhood as an immigrant to the U.S. shaped his view as a leader, and his desire to work in the life sciences. Other notable guests in Season 2 include Bruce Shook, Serial MedTech Entrepreneur, Peter Miller, CEO of OptiNose, John Witkowski, President of DSM Biomedical, and more!
Stream the episodes to hear advice on leadership in the life sciences, key leadership traits, and how the Commonwealth’s top life sciences leaders continue to grow within the industry.
Serial MedTech Entrepreneur
Election Leadership Update
On November 8, the United States will hold its mid-term elections. In Pennsylvania, two important statewide races are on the ballot this year – Governor and U.S. Senate. Both the gubernatorial and senate races have been garnering significant national attention.
Republican Candidate – Doug Mastriano (current State Senator)
Democratic Candidate - Josh Shapiro (current Attorney General)
Democratic Candidate – John Fetterman (current Lieutenant Governor)
Republican Candidate – Mehmet Oz, MD
In addition to those two races, Pennsylvania went through a process of redistricting. The redistricting process saw the Commonwealth’s congressional delegation shrink by one U.S. House seat, so we’ll have 17 representatives in the House delegation rather than 18. More information on what those elections look like can be found here.
The Pennsylvania State House and Senate districts all also went through the redistricting process. In the Pennsylvania State House all 203 House seats are up for election. Republicans hold a majority of seats in the Pennsylvania House with 113 representatives, while Democrats hold 89 seats and 1 seat is currently vacant.
In the Pennsylvania State Senate 25 of the 50 Senate seats are up for election. As it stands Republicans hold a majority of seats in the Pennsylvania Senate with 28 seats to the Democrats 21 seats (1 seat is held by an Independent).
Finally, Pennsylvania will also be electing its lieutenant governor. It is one of eighteen states that elects its lieutenant governor independent of its governor.
Pennsylvania Lieutenant Governor:
Democratic Candidate – Austin Davis (current State Representative)
Republican Candidate – Carrie DelRosso (current State Representative)
Life Sciences Pennsylvania held a multi-state congressional briefing July 18 on the importance of preparing for an emerging public health crisis – antimicrobial resistance. This was the third in a series of multi-state briefings held by a collection of state life sciences trade associations – such as the Healthcare Institute of New Jersey (HINJ), Biocom (California), MichBio, BioNJ, among many others. The previous two briefings focused on the Prescription Drug User Fee Agreement (PDUFA) and Cures 2.0.
This briefing educated attendees, particularly congressional staff, on the importance of incentivizing investment in novel antimicrobials. Additionally, it explained the unique scientific, regulatory, and economic challenges of antimicrobial innovation and stewardship.
Life Sciences PA President & CEO, Chris Molineaux, was pleased to moderate this discussion that also featured: Christopher Burns, Ph.D. – Founder, President, and CEO at Venatorx Pharmaceuticals; David Elin, MSW – Senior Director, Advocacy & Government Affairs at Cystic Fibrosis Foundation; and Tara Vijayan, MD – Medical Director, Antimicrobial Stewardship at UCLA Health.
Clockwise from top left: Tara Vijayan, UCLA Health; David Elin, Cystic Fibrosis Foundation; Christopher P. Molineaux, Life Sciences PA; and Christopher Burns, Venatorx Pharmaceuticals
New Executive Order on Drug Pricing
As the federal fiscal year comes to an end September 30, several Life Sciences Pennsylvania federal advocacy priorities need reauthorization: the User Fee Acts and the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) programs.
Timely reauthorization of the Prescription Drug User Fee Act, the Medical Device User Fee Act, and the Biosimilar User Fee Act are critical to ensure the Food and Drug Administration (FDA) can keep pace with the significant number of medicines and technologies entering the regulatory review pipeline.
Additionally, the SBIR/STTR programs are complementary programs that have been critical in providing small companies with early-stage capital funding. The funding provided through these programs is especially important for the life sciences, as it helps to de-risk the innovative products companies are pursuing and advances the development of new treatments for patients.
Life Sciences PA continues to urge its congressional delegation to include reauthorization of these program in any kind of bill – such as a continuing resolution – Congress must pass before the September 30 deadline to fund the government.
The U.S. Department of Health and Human Services is working to establish the Advanced Research Projects Agency for Health (ARPA-H). In fact, President Biden announced September 12 his intent to appoint Dr. Renee Wegrzyn as the first director of ARPA-H.
As the administration works with Congress to establish ARPA-H, a process that continues to develop, many states and regions have begun advocating for ARPA-H to be headquartered in their respective geographies. Given Pennsylvania’s life sciences leadership, Life Sciences PA encouraged the administration to strongly consider Pennsylvania as that location and had more than 40 organizations sign on to that letter. Here is the letter urging the Secretary of Health and Human Services, Xavier Becerra, to strongly consider Pennsylvania for the ARPA-H headquarters. Life Sciences PA continues to work with stakeholders throughout the Commonwealth to encourage ARPA-H to be located in Pennsylvania.
Rally for Medical Research
Life Sciences Pennsylvania was honored to take part in the annual Rally for Medical Research in Washington, D.C. This event, spearheaded by the (Pennsylvania-based) American Association for Cancer Research (AACR) brings together national, state and local organizations to advocate for robust National Institutes of Health (NIH) funding – one of Life Sciences PA’s top federal priorities – and a bipartisan issue among the Pennsylvania delegation. These meetings ensure our congressional representatives understand the importance of medical research for patients, and for our life sciences economy.
Rally for Medical Research participants gather in Washington, D.C. before going to meetings on Capitol Hill
The Pennsylvania General Assembly passed a budget that was signed into law by Governor Wolf July 8. This budget represents Governor Wolf’s last budget in office as his second-term concludes at the end of the year. The final budget agreement includes $42.7 billion in General Fund expenditures, and more than $45.2 billion when supplemental spending and federal stimulus spending are included. This increase in spending can be credited to funds received from the Federal government’s American Rescue Plan Act (ARPA) and higher than expected revenues. Life Sciences PA was pleased this year’s budget provides for an annual phase-down of the Corporate Net Income Tax (CNIT) by 1% to 8.99% beginning in January 2023, with future reductions of 0.5% annually until the rate reaches 4.99% in 2031.
The final budget also includes two funding increases. The R&D Tax Credit Cap has been increased by $5 million to an expanded cap of $60 million with $12 million set aside for small business. The Ben Franklin Technology Partners received an increase of $2.5 million bringing their total funding to $17 million. It also contains the following items of interest to Pennsylvania’s life sciences community:
$3 million to the three ($1 million each) Life Sciences Greenhouses
Up to $15,000,000 in Keystone Innovation Zone (KIZ) tax credits
13.6 percent of the state’s annual tobacco settlement payments for the Commonwealth Universal Research Enhancement (CURE) Program in the Department of Health to fund research projects conducted by Pennsylvania-based researchers, universities, medical schools and other institutions. This year’s budget continues allocations from the CURE dollars specifically for spinal injury research, pediatric cancer research and equipment grants for biotechnology research
Department of Health funding for Bio-Technology Research is included at $10,600,000
$5,000,000 in ARPA funding provided for grants to promote the growth or development of new and innovative technologies from biotechnology, life sciences, pharmaceutical and health fields.
PA Rare Disease Advisory Council Summit
The PA Rare Disease Advisory Council (PARDAC) was created through legislation in July 2017. When it was formed, Pennsylvania was only one of four states with a rare disease advisory council – an entity formed to improve the quality of life for all those affected by rare disease.
PARDAC held its Stakeholder Summit September 22 in Harrisburg, and Life Sciences PA was proud to attend this event that provided an update and background on several issues important to Pennsylvania’s rare disease community. PA Rare Disease Caucus Co-Chairs: Senator Judy Ward, Representative Mark Longietti, Senator Maria Collett, Representative Barbara Gleim, and Acting Department of Human Services Secretary Meg Snead, were all in attendance. PARDAC provided an update on its PA Rare Disease Needs Assessment Survey and they continue to seek input from persons with a rare disease who reside in the Commonwealth.
B. Braun Ribbon Cutting
Life Sciences PA was honored to participate in a ribbon-cutting ceremony for B. Braun’s new, 310,000 square feet medical device manufacturing facility in Allentown. This facility – a state-of-the-art, $200 million expansion project – doubles the footprint of B.Braun’s current Allentown facility and will increase workforce there to more than 1,700. The investment will benefit healthcare providers and millions of patients across the country by adding capacity to manufacture critical life-sustaining medical equipment here in the U.S. The event was attended by company leadership and public officials from the Lehigh Valley and represents a significant investment in Pennsylvania’s life sciences community.
LIFE SCIENCES FUTURE - BIOPHARM
October 6-7, 2022| In-Person & Virtual
A Life Sciences PA signature event, Life Sciences Future - BioPharm returned in-person in Philadelphia this past October. Biotech and Pharmaceutical leaders from across the Commonwealth attended a full day of Company and Investor Reverse Pitches, Keynote Sessions, Poster Presentations, One-on-One Partnering, and concluded with a networking cocktail hour. C-Suite members also attended a live recording of Being a Life Sciences Leader during Breakfast in the C-Suite. Attendees then had the opportunity to login the next day to attend virtual conference sessions and watch any on-demand recordings they may have missed on day one.
The conference covered a variety of timely topics including the state of the industry, market insights, academic and industry collaboration, real estate and development, investor relations, and more! The in-person event concluded with a Patient Spotlight, highlighting a young boy who received life-altering gene therapy treatment.
OPERATOR'S MANUAL - QUARTERLY SERIES
Life Sciences PA constantly evolves programming to meet the needs of members and help them reach their organizational goals. LSPA continued the Operator's Manual in quarter 4, a series of quarterly educational sessions to give advice to member companies on topics like fundraising, finance, operations and legal considerations. In Q4, LSPA introduced a new series to the manual, Phase-to-Phase: The Guide to Drug Development, to give insight on the drug development process and important considerations. Thanks to the generous support of the sponsors of these series, all sessions are free to members, giving them the insight into the areas of business operations they need.
Phase-to-Phase: The Guide to Drug Development launched in October 2022 with experts from FlowMetric, a KCAS company, who discussed Discovery / Lead Optimization, Pre-clinical Tox, Translational, and Clinical Trials.
The Art of Fundraising features experts from Danforth Advisors who discuss real life scenarios and advice on topics such as preparing for the seed round, different stages of fundraising, board topics, and more. Hundreds of LSPA members took advantage of this series to ask questions and get live feedback from the Danforth Advisors team.
Attendees can have all their legal questions answered at the Legal Answers Workshop. Experts from Ballard Spahr discuss a variety of topics in this LAW series, including protecting your IP, licensing agreements and partnering.
LSPA's first quarterly series, the Finance Operations Series has been assisting attendees with taking control of their financials for over a year. Experts at KPMG cover topics such as audits of financial statements, PA state budget considerations, and deferred compensation
CHIEF EXECUTIVE OFFICER DINNER
November 29, 2022 | Merion Golf Club
Life Sciences PA's most exclusive event of the year, the CEO Dinner welcomes leaders across hundreds of organizations for the opportunity to network, connect and hear from a high-level speaker. This year, Greg Deavens, President & CEO of Independence Health Group, addressed the crowd discussing hot topics such as health equity and insurance considerations around pharmaceuticals.
"DIVERSITY AND INCLUSION IS A MARATHON, NOT A SPRINT."
- Marcia O'Connor, The O'Connor Group
TELL ME ABOUT YOUR DE&I INITIATIVES
September 20, 2022 | Hosted Virtually
The third edition of Life Sciences PA's evolving DE&I series welcomed three more experts to discuss success and failures while implementing diversity and inclusion efforts in their organizations. Speakers discussed the importance of providing a forum for employees to address historically taboo workplace topics such as ageism, ableism, and more. When building a company culture, it is imperative that leaders weave D&I into the fabric of the organization.
Employers often place D&I into the responsibility of human resources. HR consultant Marcia O'Connor of the O'Connor Group shares that HR can be a piece of the solution, but it cannot be the entire solution. Employee engagement is key in developing a thriving DE&I-focused environment. Attendees wrapped the conversation by networking with the panelists and asked questions on how to best implement the tactics discussed.
ULTIMATE NETWORKING DAY
To close the year, Life Sciences PA hosted the Ultimate Networking Day, an opportunity for different members to make valuable connections throughout the day, and end with a final holiday celebration in our new office space.
Four legends, one stage! Long-time experts in the life sciences gather to discussed how they stay active in the community at this leadership panel. Following the event, Life Sciences PA awarded panelist Bruce Peacock for his work as a transformer in the industry
Patient group representatives gathered in the LSPA offices to mingle with legislators and discuss their priorities for legislation moving into 2023
December 8, 2022 | Life Sciences PA Headquarters
The Life Sciences Center has officially opened its doors to members in our new office space in King of Prussia. A central Member benefit, the Life Sciences Center offers a space to gather your team for meetings or trainings, network with other Life Sciences PA Members, or even drop your laptop and work away from home for the afternoon.
With a brand new state-of-the-art Zoom Room, bring your local and virtual colleagues together @LSPA. The Life Sciences Center provides members 2 complimentary hours at the center per day - come utilize the space! From small huddle rooms, to a board room, a large open flex space to a full kitchen and coffee bar, the Center is our member clubhouse designed to meet your needs.
Life Sciences PA hosted members once again @LSPA for two Open Houses in September. Members gathered to network over coffee and pastries, and learn about their new clubhouse.
If you want to book space at the Life Sciences Center, contact Kelly Catoia (email@example.com) Membership Assistant/Life Sciences Center Coordinator.
Welcome 2022 New Members!
Welcome 2022 New Members!
Welcome 2022 New Members!
Alvarez & Marsal (A&M)
Alvarez & Marsal (A&M)
Axiom Healthcare Strategies
Bowers R&D Associates
BriGene Biosciences Inc.
CSC Leasing Company
Ciscovery Bio Inc
Clear Thoughts Foundation
Comvia Group, LLC
Cushman & Wakefield
D2 Groups, LLC
EvaluatePharma USA, Inc.
Gattuso Development Partners
Klasko Immigration Law Partners, LLP
Life Science Wealth
Little Hercules Foundation
National Blood Clot Alliance
National CMV Foundation
Nexstone Immunology, Inc.
Paragon Biosciences, LLC
Phio Pharmaceuticals, Inc.
Privacy Aviator LLC
Purolite, An Ecolab Company
QIAGEN Sciences Inc
QRD Pharma LLC
Qnapsyn Biosciences, Inc.
Radiant Biotherapeutics, Inc
Scientific and Medical Affairs Consulting
Somatolink Foundation, Inc.
Somatolink Foundation, Inc.
Tarkett USA Inc.
Tarkett USA Inc.
The Emmes Company LLC
The Neutrino Donut, LLC
The Neutrino Donut, LLC